Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss.
Monteiro
F
F
Laboratory of Transplantation Immunology, School of Medicine, University of São Paulo, Brazil.
Mineiro
C
C
Rodrigues
H
H
de Paula
F J
FJ
Kalil
J
J
D000704:Analysis of Variance; D003602:Cytotoxicity, Immunologic; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology; D006085:Graft Survival / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D007074:Immunoglobulin G / Q000097:blood*; D007518:Isoantibodies / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology*; D008991:Monitoring, Physiologic; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D013997:Time Factors; D017211:Treatment Failure
D015395:Histocompatibility Antigens Class I; D007074:Immunoglobulin G; D007518:Isoantibodies